| UniProt ID | TOIP2_HUMAN | |
|---|---|---|
| UniProt AC | Q8NFQ8 | |
| Protein Name | Torsin-1A-interacting protein 2 | |
| Gene Name | TOR1AIP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 470 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass membrane protein. Nucleus membrane. |
|
| Protein Description | Required for endoplasmic reticulum integrity. Regulates the distribution of TOR1A between the endoplasmic reticulum and the nuclear envelope as well as induces TOR1A, TOR1B and TOR3A ATPase activity.. | |
| Protein Sequence | MADSGLREPQEDSQKDLENDPSVNSQAQETTIIASNAEEAEILHSACGLSKDHQEVETEGPESADTGDKSESPDEANVGKHPKDKTEDENKQSFLDGGKGHHLPSENLGKEPLDPDPSHSPSDKVGRADAHLGSSSVALPKEASDGTGASQEPPTTDSQEAQSPGHSSAGQEGEDTLRRRLLAPEAGSHPQQTQKLEEIKENAQDTMRQINKKGFWSYGPVILVVLVVAVVASSVNSYYSSPAQQVPKNPALEAFLAQFSQLEDKFPGQSSFLWQRGRKFLQKHLNASNPTEPATIIFTAAREGRETLKCLSHHVADAYTSSQKVSPIQIDGAGRTWQDSDTVKLLVDLELSYGFENGQKAAVVHHFESFPAGSTLIFYKYCDHENAAFKDVALVLTVLLEEETLEASVGPRETEEKVRDLLWAKFTNSDTPTSFNHMDSDKLSGLWSRISHLVLPVQPVSSIEEQGCLF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MADSGLREP ------CCCCCCCCC | 21.48 | 21406692 | |
| 4 | Phosphorylation | ----MADSGLREPQE ----CCCCCCCCCCH | 30.13 | 25159151 | |
| 7 | Methylation | -MADSGLREPQEDSQ -CCCCCCCCCCHHHH | 58.01 | 115918749 | |
| 13 | Phosphorylation | LREPQEDSQKDLEND CCCCCHHHHHHHHCC | 38.08 | 28355574 | |
| 22 | Phosphorylation | KDLENDPSVNSQAQE HHHHCCCCCCHHHHH | 36.47 | 26471730 | |
| 25 | Phosphorylation | ENDPSVNSQAQETTI HCCCCCCHHHHHEEE | 25.41 | 28348404 | |
| 30 | Phosphorylation | VNSQAQETTIIASNA CCHHHHHEEEEECCH | 15.94 | 28348404 | |
| 31 | Phosphorylation | NSQAQETTIIASNAE CHHHHHEEEEECCHH | 15.05 | 28348404 | |
| 58 | Phosphorylation | KDHQEVETEGPESAD CCCCCCCCCCCCCCC | 51.96 | 29978859 | |
| 63 | Phosphorylation | VETEGPESADTGDKS CCCCCCCCCCCCCCC | 34.28 | 29978859 | |
| 66 | Phosphorylation | EGPESADTGDKSESP CCCCCCCCCCCCCCC | 47.17 | 23663014 | |
| 70 | Phosphorylation | SADTGDKSESPDEAN CCCCCCCCCCCCCCC | 48.31 | 30278072 | |
| 72 | Phosphorylation | DTGDKSESPDEANVG CCCCCCCCCCCCCCC | 44.75 | 30278072 | |
| 80 | Acetylation | PDEANVGKHPKDKTE CCCCCCCCCCCCCCC | 53.07 | 26051181 | |
| 86 | Phosphorylation | GKHPKDKTEDENKQS CCCCCCCCCCCCCCC | 59.82 | - | |
| 93 | Phosphorylation | TEDENKQSFLDGGKG CCCCCCCCCCCCCCC | 29.41 | 25159151 | |
| 105 | Phosphorylation | GKGHHLPSENLGKEP CCCCCCCCCCCCCCC | 45.54 | 30576142 | |
| 118 | Phosphorylation | EPLDPDPSHSPSDKV CCCCCCCCCCCCCCC | 43.93 | 30266825 | |
| 120 | Phosphorylation | LDPDPSHSPSDKVGR CCCCCCCCCCCCCCC | 30.36 | 29255136 | |
| 122 | Phosphorylation | PDPSHSPSDKVGRAD CCCCCCCCCCCCCCC | 53.75 | 30266825 | |
| 134 | Phosphorylation | RADAHLGSSSVALPK CCCCCCCCCCEECCC | 26.29 | 25159151 | |
| 135 | Phosphorylation | ADAHLGSSSVALPKE CCCCCCCCCEECCCC | 27.34 | 25159151 | |
| 136 | Phosphorylation | DAHLGSSSVALPKEA CCCCCCCCEECCCCC | 17.07 | 25159151 | |
| 144 | Phosphorylation | VALPKEASDGTGASQ EECCCCCCCCCCCCC | 37.35 | 29978859 | |
| 147 | Phosphorylation | PKEASDGTGASQEPP CCCCCCCCCCCCCCC | 34.27 | 29978859 | |
| 150 | Phosphorylation | ASDGTGASQEPPTTD CCCCCCCCCCCCCCC | 36.10 | 29978859 | |
| 155 | Phosphorylation | GASQEPPTTDSQEAQ CCCCCCCCCCCHHHC | 54.68 | 28450419 | |
| 156 | Phosphorylation | ASQEPPTTDSQEAQS CCCCCCCCCCHHHCC | 39.15 | 28450419 | |
| 158 | Phosphorylation | QEPPTTDSQEAQSPG CCCCCCCCHHHCCCC | 28.03 | 21712546 | |
| 163 | Phosphorylation | TDSQEAQSPGHSSAG CCCHHHCCCCCCCCC | 39.64 | 25159151 | |
| 167 | Phosphorylation | EAQSPGHSSAGQEGE HHCCCCCCCCCCCCH | 28.00 | 28450419 | |
| 168 | Phosphorylation | AQSPGHSSAGQEGED HCCCCCCCCCCCCHH | 30.64 | 28450419 | |
| 176 | Phosphorylation | AGQEGEDTLRRRLLA CCCCCHHHHHHHHCC | 20.19 | 28450419 | |
| 188 | Phosphorylation | LLAPEAGSHPQQTQK HCCCCCCCCHHHHHH | 38.76 | 26462736 | |
| 193 | Phosphorylation | AGSHPQQTQKLEEIK CCCCHHHHHHHHHHH | 23.56 | 30266825 | |
| 195 | Ubiquitination | SHPQQTQKLEEIKEN CCHHHHHHHHHHHHH | 62.34 | 21890473 | |
| 200 | Ubiquitination | TQKLEEIKENAQDTM HHHHHHHHHHHHHHH | 48.47 | 21890473 | |
| 207 | Sulfoxidation | KENAQDTMRQINKKG HHHHHHHHHHHHHCC | 3.90 | 21406390 | |
| 286 | N-linked_Glycosylation | KFLQKHLNASNPTEP HHHHHHHCCCCCCCC | 40.83 | - | |
| 289 | N-linked_Glycosylation | QKHLNASNPTEPATI HHHHCCCCCCCCCEE | 45.14 | UniProtKB CARBOHYD | |
| 309 | Ubiquitination | REGRETLKCLSHHVA CCCHHHHHHHHHHHH | 40.32 | - | |
| 310 | Glutathionylation | EGRETLKCLSHHVAD CCHHHHHHHHHHHHH | 5.47 | 22555962 | |
| 324 | Ubiquitination | DAYTSSQKVSPIQID HCCCCCCCCCCEEEC | 46.78 | - | |
| 326 | Phosphorylation | YTSSQKVSPIQIDGA CCCCCCCCCEEECCC | 24.26 | 20068231 | |
| 425 | Ubiquitination | VRDLLWAKFTNSDTP HHHHHHHHCCCCCCC | 40.93 | 21890473 | |
| 433 | Phosphorylation | FTNSDTPTSFNHMDS CCCCCCCCCCCCCCH | 48.30 | - | |
| 440 | Phosphorylation | TSFNHMDSDKLSGLW CCCCCCCHHHCCHHH | 29.12 | - | |
| 442 | Ubiquitination | FNHMDSDKLSGLWSR CCCCCHHHCCHHHHH | 48.80 | 21890473 | |
| 468 | Glutathionylation | SSIEEQGCLF----- CCHHHCCCCC----- | 3.34 | 22555962 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TOIP2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOIP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOIP2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120 AND SER-163, ANDMASS SPECTROMETRY. | |